SMTL ID : 4ot5.1

Crystal structure of BTK kinase domain complexed with 4-tert-Butyl-N-(3-{8-[4-(4-methyl-piperazine-1-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-benzamide

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.55 Å
Oligo State
monomer
Ligands
1 x 481: 4-tert-butyl-N-{3-[8-({4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}amino)imidazo[1,2-a]pyrazin-6-yl]phenyl}benzamide(Non-covalent)
2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Lou, Y. et al., Structure-Based Drug Design of RN486, a Potent and Selective Bruton's Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis. J.Med.Chem. (2015)
Release Date
2014-05-14
Peptides
Tyrosine-protein kinase BTK: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence

4ot6.1 | 4otq.1 | 4otr.1 | 4rfy.1 | 4rfz.1 | 4rg0.1 | 6ep9.1 | 6hrp.1 | 6hrt.1